Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
34 participants
OBSERVATIONAL
2000-01-01
2018-01-02
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Gastrointestinal Stromal Tumors (GIST) Registry
NCT00507273
Laparoscopic Endoscopic Cooperative Surgery in the Treatment of Gastric Stromal Tumors
NCT03601234
Surgery in Gastrointestinal Stromal Tumors (GISTs) for Treatment, Tumor Modeling, and Genomic Analysis
NCT04557969
Laparoscopic Management of Gastrointestinal Stromal Tumor of Stomach
NCT03722056
Follow-up of the Natural Course of the Small EUS-suspected Gastric Gastointestinal Stromal Tumors
NCT01084460
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
They have been the subject of much controversy in terms of their histogenesis, classification, treatment and prognosis. GISTs are histologically similar to smooth muscle and nerve tumors such as leiomyomas, leiomyosarcomas or schwannomas. Currently they are well characterized with the recent discovery of the C-KIT gene mutation and the expression by tumor cells of the C-KIT protein.
Moreover, the discovery of this receptor is at the origin of the introduction of a "targeted therapy": an anti-tyrosine kinase molecule having revolutionized the therapeutic management of these tumors. However, the standard curative treatment of GIST remains complete surgical resection with negative margin from the tumor.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
prognostic factors of gastrointestinal stromal tumors
for the patient diagnosed with gastic GIST , they underwent subtotal or total gastrectomy.
total or subtotal gastrectomy
resection of the gastric tumor
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
total or subtotal gastrectomy
resection of the gastric tumor
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
10 Years
90 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Université de Sousse
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
ammar houssem
Doctor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
ALI BEN ALI, PROFESSOR
Role: STUDY_DIRECTOR
university of sousse
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
U23453
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.